Poly Medicure Dirección
Dirección controles de criterios 2/4
El CEO de Poly Medicure's es Himanshu Baid , nombrado en Sep 1995, tiene una permanencia de 28.58 años. compensación anual total es ₹130.06M, compuesta por 42.3% salario y 57.7% primas, incluidas acciones y opciones de la empresa. posee directamente un 12.24% de las acciones de la empresa, por valor de ₹18.19B. La antigüedad media del equipo directivo y de la junta directiva es de 5.8 años y 10.8 años, respectivamente.
Información clave
Himanshu Baid
Chief Executive Officer (CEO)
₹130.1m
Compensación total
| Porcentaje del salario del CEO | 42.3% |
| Permanencia del CEO | 28.8yrs |
| Participación del CEO | 12.2% |
| Permanencia media de la dirección | 6yrs |
| Promedio de permanencia en la Junta Directiva | 11yrs |
Actualizaciones recientes de la dirección
Recent updates
Poly Medicure's (NSE:POLYMED) Promising Earnings May Rest On Soft Foundations
May 25
Why You Should Care About Poly Medicure's (NSE:POLYMED) Strong Returns On Capital
May 12Poly Medicure Limited's (NSE:POLYMED) Share Price Not Quite Adding Up
Mar 23Here's Why We Think Poly Medicure (NSE:POLYMED) Might Deserve Your Attention Today
Feb 15Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 16Is Now The Time To Put Poly Medicure (NSE:POLYMED) On Your Watchlist?
Nov 14Poly Medicure (NSE:POLYMED) Has More To Do To Multiply In Value Going Forward
Oct 24Shareholders Will Probably Hold Off On Increasing Poly Medicure Limited's (NSE:POLYMED) CEO Compensation For The Time Being
Sep 22Poly Medicure (NSE:POLYMED) Is Increasing Its Dividend To ₹3.00
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Aug 12Here's Why We Think Poly Medicure (NSE:POLYMED) Is Well Worth Watching
Jul 13Poly Medicure (NSE:POLYMED) Is Reinvesting At Lower Rates Of Return
Jun 16Be Wary Of Poly Medicure (NSE:POLYMED) And Its Returns On Capital
Mar 02We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Feb 14Capital Allocation Trends At Poly Medicure (NSE:POLYMED) Aren't Ideal
Oct 16We Think Poly Medicure (NSE:POLYMED) Can Stay On Top Of Its Debt
Sep 28Poly Medicure (NSE:POLYMED) Has Affirmed Its Dividend Of ₹2.50
Sep 08Here's Why Poly Medicure (NSE:POLYMED) Can Manage Its Debt Responsibly
Jun 25A Look At The Intrinsic Value Of Poly Medicure Limited (NSE:POLYMED)
Jun 07Poly Medicure (NSE:POLYMED) Will Want To Turn Around Its Return Trends
May 23With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Feb 23There Are Reasons To Feel Uneasy About Poly Medicure's (NSE:POLYMED) Returns On Capital
Feb 04Poly Medicure (NSE:POLYMED) Seems To Use Debt Quite Sensibly
Jan 12With EPS Growth And More, Poly Medicure (NSE:POLYMED) Is Interesting
Oct 14Poly Medicure (NSE:POLYMED) Could Easily Take On More Debt
Jul 07Poly Medicure (NSE:POLYMED) Will Will Want To Turn Around Its Return Trends
Jun 18Poly Medicure's (NSE:POLYMED) Solid Profits Have Weak Fundamentals
May 31Earnings Update: Here's Why Analysts Just Lifted Their Poly Medicure Limited (NSE:POLYMED) Price Target To ₹1,195
May 26Shareholders of Poly Medicure (NSE:POLYMED) Must Be Delighted With Their 448% Total Return
Mar 01I Ran A Stock Scan For Earnings Growth And Poly Medicure (NSE:POLYMED) Passed With Ease
Feb 16How Much Is Poly Medicure Limited (NSE:POLYMED) CEO Getting Paid?
Feb 01Did Poly Medicure Limited (NSE:POLYMED) Insiders Sell Shares?
Jan 17Poly Medicure Limited's (NSE:POLYMED) Stock Is Going Strong: Is the Market Following Fundamentals?
Dec 09
Announcing: Poly Medicure (NSE:POLYMED) Stock Increased An Energizing 205% In The Last Five Years
Nov 24Is Poly Medicure (NSE:POLYMED) Using Too Much Debt?
Nov 09Many Would Be Jealous Of Poly Medicure's (NSE:POLYMED) Returns On Capital
Oct 26Have Insiders Been Selling Poly Medicure Limited (NSE:POLYMED) Shares?
Oct 06Should You Be Adding Poly Medicure (NSE:POLYMED) To Your Watchlist Today?
Sep 17Should Poly Medicure Limited (NSE:POLYMED) Be Part Of Your Dividend Portfolio?
Sep 02Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Mar 31 2024 | n/a | n/a | ₹3b |
| Dec 31 2023 | n/a | n/a | ₹2b |
| Sep 30 2023 | n/a | n/a | ₹2b |
| Jun 30 2023 | n/a | n/a | ₹2b |
| Mar 31 2023 | ₹130m | ₹55m | ₹2b |
| Dec 31 2022 | n/a | n/a | ₹2b |
| Sep 30 2022 | n/a | n/a | ₹1b |
| Jun 30 2022 | n/a | n/a | ₹1b |
| Mar 31 2022 | ₹107m | ₹49m | ₹1b |
| Dec 31 2021 | n/a | n/a | ₹1b |
| Sep 30 2021 | n/a | n/a | ₹1b |
| Jun 30 2021 | n/a | n/a | ₹1b |
| Mar 31 2021 | ₹92m | ₹44m | ₹1b |
| Dec 31 2020 | n/a | n/a | ₹1b |
| Sep 30 2020 | n/a | n/a | ₹1b |
| Jun 30 2020 | n/a | n/a | ₹1b |
| Mar 31 2020 | ₹62m | ₹35m | ₹959m |
| Dec 31 2019 | n/a | n/a | ₹947m |
| Sep 30 2019 | n/a | n/a | ₹858m |
| Jun 30 2019 | n/a | n/a | ₹719m |
| Mar 31 2019 | ₹44m | ₹14m | ₹654m |
| Mar 31 2018 | ₹41m | ₹14m | ₹706m |
Compensación vs. Mercado: La compensación total de Himanshu($USD1.56M) está por encima de la media de empresas de tamaño similar en el mercado Indian ($USD437.55K).
Compensación vs. Ingresos: La compensación de Himanshu ha aumentado más de un 20% en el último año.
CEO
Himanshu Baid (56 yo)
28.8yrs
Permanencia
₹130,063,000
Compensación
Mr. Himanshu Baid has been the Managing Director of Poly Medicure Limited since September 20, 1995 and serves as Chief Executive Officer. Mr. Baid is an Electronics Engineer and has experience in respect t...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, MD & Director | 28.8yrs | ₹130.06m | 12.24% ₹ 21.5b | |
| Founder & Non Executive Director | no data | ₹1.43m | 2.38% ₹ 4.2b | |
| Chief Financial Officer | 2.9yrs | ₹9.90m | sin datos | |
| Company Secretary & Compliance Officer | 9.1yrs | ₹1.67m | sin datos | |
| Joint MD & Executive Director | no data | ₹124.73m | 13.07% ₹ 22.9b | |
| President of Corporate Sales & Marketing | 2.2yrs | ₹17.15m | 1.75% ₹ 3.1b | |
| Assistant Vice President of Finance & Accounts | no data | sin datos | sin datos | |
| Senior Vice President of Domestic Sales & Marketing | no data | ₹5.79m | sin datos | |
| President of R&D | no data | ₹5.61m | sin datos | |
| President of Sales & Marketing - India | no data | ₹8.61m | sin datos |
6.0yrs
Permanencia media
56yo
Promedio de edad
Equipo directivo experimentado: El equipo directivo de POLYMED es experimentado (5.8 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| CEO, MD & Director | 29.3yrs | ₹130.06m | 12.24% ₹ 21.5b | |
| Founder & Non Executive Director | 29.3yrs | ₹1.43m | 2.38% ₹ 4.2b | |
| Joint MD & Executive Director | 29.3yrs | ₹124.73m | 13.07% ₹ 22.9b | |
| Non-Executive Independent Director | 4yrs | ₹1.58m | sin datos | |
| Non-Executive Independent Chairman | 19.1yrs | ₹1.60m | sin datos | |
| Non-Executive Independent Director | 26.8yrs | ₹1.40m | 0.0011% ₹ 2.0m | |
| Non-Executive Director | 9.9yrs | ₹1.43m | 3.19% ₹ 5.6b | |
| Non-Executive Independent Director | 12.1yrs | ₹1.55m | sin datos | |
| Non-Executive Independent Director | 3.8yrs | ₹1.48m | 0.000040% ₹ 70.1k | |
| Non-Executive Independent Director | 7.3yrs | ₹1.45m | sin datos | |
| Non-Executive Non Independent Director | 6.1yrs | sin datos | sin datos | |
| Independent Director | 2.2yrs | ₹900.00k | sin datos |
11.0yrs
Permanencia media
64yo
Promedio de edad
Junta con experiencia: Los miembros de la junta directiva de POLYMED son experimentados ( 10.8 años antigüedad media).